ACS Nano,
Journal Year:
2020,
Volume and Issue:
14(10), P. 12281 - 12290
Published: Oct. 6, 2020
The
three
design
criteria
of
anticancer
nanomedicines
to
improve
efficacy
and
reduce
toxicity
have
been
debated
for
decades:
(1)
Nanomedicines
increase
drug
accumulation
through
enhanced
permeability
retention
(EPR)
in
tumors
efficacy.
(2)
Long
systemic
circulation
with
high
plasma
concentration
reduces
reticuloendothelial
system
(RES)
clearance
decreases
the
normal
organs
toxicity,
enhance
EPR
effect.
(3)
A
universal
nanodelivery
platform
based
on
long
can
be
developed
deliver
different
drugs.
Although
these
repeatedly
confirmed
preclinical
xenograft
cancers,
majority
failed
clinical
efficacy,
while
efficacies/safety
successful
are
inconsistent
criteria.
First,
debate
over
tumor
may
mixed
two
questions
missed
more
clinically
relevant
comparisons
versus
free
When
compared
tissues,
has
both
mouse
human
cancers.
However,
not
drugs,
despite
outstanding
improvement
Heterogeneity
cancers
occurs
small/large
molecules
nanomedicines,
which
cannot
fully
explain
poor
translation
nanomedicines'
from
cancer
models
patients.
Second,
long-circulation
nanomedicine
should
used
as
a
criterion
because
it
does
further
by
patients
nor
universally
distribution
organs.
In
contrast,
change
tissue
alter
efficacy/safety.
Third,
that
uses
same
drugs
is
feasible.
Rather,
drug-specific
systems
required
overcome
intrinsic
shortcomings
delivered
determined
physicochemical,
pharmacokinetic,
pharmacodynamic
properties
nanocarriers
their
Journal of Nanobiotechnology,
Journal Year:
2018,
Volume and Issue:
16(1)
Published: Sept. 19, 2018
Nanomedicine
and
nano
delivery
systems
are
a
relatively
new
but
rapidly
developing
science
where
materials
in
the
nanoscale
range
employed
to
serve
as
means
of
diagnostic
tools
or
deliver
therapeutic
agents
specific
targeted
sites
controlled
manner.
Nanotechnology
offers
multiple
benefits
treating
chronic
human
diseases
by
site-specific,
target-oriented
precise
medicines.
Recently,
there
number
outstanding
applications
nanomedicine
(chemotherapeutic
agents,
biological
immunotherapeutic
etc.)
treatment
various
diseases.
The
current
review,
presents
an
updated
summary
recent
advances
field
nanomedicines
based
drug
through
comprehensive
scrutiny
discovery
application
nanomaterials
improving
both
efficacy
novel
old
drugs
(e.g.,
natural
products)
selective
diagnosis
disease
marker
molecules.
opportunities
challenges
from
synthetic/natural
sources
their
clinical
also
discussed.
In
addition,
we
have
included
information
regarding
trends
perspectives
area.
Journal of Hematology & Oncology,
Journal Year:
2021,
Volume and Issue:
14(1)
Published: May 31, 2021
Abstract
Cancer
is
a
disease
with
complex
pathological
process.
Current
chemotherapy
faces
problems
such
as
lack
of
specificity,
cytotoxicity,
induction
multi-drug
resistance
and
stem-like
cells
growth.
Nanomaterials
are
materials
in
the
nanorange
1–100
nm
which
possess
unique
optical,
magnetic,
electrical
properties.
used
cancer
therapy
can
be
classified
into
several
main
categories.
Targeting
cells,
tumor
microenvironment,
immune
system,
these
nanomaterials
have
been
modified
for
wide
range
therapies
to
overcome
toxicity
enhance
drug
capacity
well
bioavailability.
Although
number
studies
has
increasing,
approved
nano-drugs
not
increased
much
over
years.
To
better
improve
clinical
translation,
further
research
needed
targeted
delivery
by
nano-carriers
reduce
toxicity,
permeability
retention
effects,
minimize
shielding
effect
protein
corona.
This
review
summarizes
novel
fabricated
use,
discusses
current
limitations
obstacles
that
hinder
translation
from
provides
suggestions
more
efficient
adoption
therapy.
Journal of Nanomaterials,
Journal Year:
2019,
Volume and Issue:
2019, P. 1 - 26
Published: Feb. 27, 2019
The
study
of
nanostructured
drug
delivery
systems
allows
the
development
novel
platforms
for
efficient
transport
and
controlled
release
molecules
in
harsh
microenvironment
diseased
tissues
living
systems,
thus
offering
a
wide
range
functional
nanoplatforms
smart
application
biotechnology
nanomedicine.
This
article
highlights
recent
advances
nanocarriers
composed
organic
(including
polymeric
micelles
vesicles,
liposomes,
dendrimers,
hydrogels)
inorganic
quantum
dots,
gold
mesoporous
silica
nanoparticles)
materials.
Despite
remarkable
developments
synthetic
methodologies,
most
all
nanocarriers’
action
is
associated
with
number
unwanted
side
effects
that
diminish
their
use
nanomedicine
applications.
some
critical
issues
design
engineering
nanocarrier
applications,
arising
from
complex
environment
multiform
interactions
established
within
specific
biological
media.
Nanomaterials,
Journal Year:
2020,
Volume and Issue:
10(7), P. 1403 - 1403
Published: July 19, 2020
The
complexity
of
some
diseases-as
well
as
the
inherent
toxicity
certain
drugs-has
led
to
an
increasing
interest
in
development
and
optimization
drug-delivery
systems.
Polymeric
nanoparticles
stand
out
a
key
tool
improve
drug
bioavailability
or
specific
delivery
at
site
action.
versatility
polymers
makes
them
potentially
ideal
for
fulfilling
requirements
each
particular
system.
In
this
review,
summary
state-of-the-art
panorama
polymeric
systems
has
been
conducted,
focusing
mainly
on
those
applications
which
corresponding
disease
involves
important
morbidity,
considerable
reduction
life
quality
patients-or
even
high
mortality.
A
revision
use
ocular
delivery,
cancer
diagnosis
treatment,
nutraceutical
was
carried
out,
short
discussion
about
future
prospects
these
is
included.
Nanoscale Research Letters,
Journal Year:
2021,
Volume and Issue:
16(1)
Published: Dec. 1, 2021
Abstract
Cancer
is
one
of
the
leading
causes
death
and
morbidity
with
a
complex
pathophysiology.
Traditional
cancer
therapies
include
chemotherapy,
radiation
therapy,
targeted
immunotherapy.
However,
limitations
such
as
lack
specificity,
cytotoxicity,
multi-drug
resistance
pose
substantial
challenge
for
favorable
treatment.
The
advent
nanotechnology
has
revolutionized
arena
diagnosis
Nanoparticles
(1–100
nm)
can
be
used
to
treat
due
their
specific
advantages
biocompatibility,
reduced
toxicity,
more
excellent
stability,
enhanced
permeability
retention
effect,
precise
targeting.
are
classified
into
several
main
categories.
nanoparticle
drug
delivery
system
particular
utilizes
tumor
environment
characteristics.
not
only
solve
conventional
treatment
but
also
overcome
multidrug
resistance.
Additionally,
new
mechanisms
unraveled
studied,
nanoparticles
being
investigated
vigorously.
Various
therapeutic
implications
nanoformulations
have
created
brand
perspectives
most
research
limited
in
vivo
vitro
studies,
number
approved
nanodrugs
much
amplified
over
years.
This
review
discusses
numerous
types
nanoparticles,
targeting
mechanisms,
nanotherapeutics
oncological
Further,
we
summarize
current
perspective,
advantages,
challenges
clinical
translation.
Cancer Nanotechnology,
Journal Year:
2019,
Volume and Issue:
10(1)
Published: Dec. 1, 2019
Abstract
Background
In
recent
years,
disease
treatment
has
evolved
strategies
that
require
increase
in
pharmaceutical
agent’s
efficacy
and
selectivity
while
decreasing
their
toxicity
normal
tissues.
These
requirements
have
led
to
the
development
of
nanoscale
liposome
systems
for
drug
release.
This
review
focuses
on
lipid
features,
pharmacological
properties
liposomal
formulations
clinical
studies
application.
Main
body
Several
lipids
are
available,
but
could
affect
or
efficiency
formulations.
Many
been
developed
currently
market.
Proper
selection
is
essential
effect
be
improved.
Most
use
mainly
zwitterionic,
cationic
anionic
lipids,
PEG
and/or
cholesterol,
which
different
effects
stability,
pharmacokinetics
delivery
formulation.
Clinical
trials
shown
liposomes
pharmacologically
pharmacokinetically
more
efficient
than
drug-alone
treating
acute
myeloid
leukemia,
hepatitis
A,
pain
management,
ovary,
gastric
breast
lung
cancer,
among
others.
Conclusion
Liposomal
less
toxic
drugs
alone
better
parameters.
Although
they
seem
first
choice
various
diseases,
further
research
about
dosage
regimen
regarding
dose
time
needs
carried
out.
Frontiers in Pharmacology,
Journal Year:
2021,
Volume and Issue:
12
Published: Feb. 3, 2021
Advances
in
nanotechnology
have
favored
the
development
of
novel
colloidal
formulations
able
to
modulate
pharmacological
and
biopharmaceutical
properties
drugs.
The
peculiar
physico-chemical
technological
nanomaterial-based
therapeutics
allowed
for
several
successful
applications
treatment
cancer.
size,
shape,
charge
patterning
nanoscale
therapeutic
molecules
are
parameters
that
need
be
investigated
modulated
order
promote
optimize
cell
tissue
interaction.
In
this
review,
use
polymeric
nanoparticles
as
drug
delivery
systems
anticancer
compounds,
their
ability
efficiently
localized
specific
tumor
tissues
been
described.
nanoencapsulation
antitumor
active
compounds
is
a
promising
approach
improve
efficacy
various
treatments.
Chemical Society Reviews,
Journal Year:
2020,
Volume and Issue:
49(4), P. 1253 - 1321
Published: Jan. 1, 2020
Bismuth-containing
nanomaterials
offer
a
new
opportunity
to
move
beyond
current
achievements
in
the
fields
of
drug
delivery,
diagnosis,
cancer
therapy,
biosensing,
and
tissue
engineering.
This
review
describes
emerging
applications
perspective
these
nanoparticles.